{"id":728322,"date":"2023-02-02T13:18:41","date_gmt":"2023-02-02T18:18:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/"},"modified":"2023-02-02T13:18:41","modified_gmt":"2023-02-02T18:18:41","slug":"scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/","title":{"rendered":"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock"},"content":{"rendered":"
\n

PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc.\u00a0(Nasdaq: SRNE, \u201cSorrento\u201d) today posted a supplement to its previously issued \u201cFrequently Asked Questions\u201d document under the \u201cInvestors\u201d section of its website at www.sorrentotherapeutics.com<\/a> regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company held by Sorrento.<\/p>\n

The supplement to the FAQs provides notice regarding the Depository Trust and Clearing Corporation\u2019s removal of the contra-CUSIP on Scilex common stock that was distributed as a dividend to Sorrento\u2019s stockholders and provides notice to brokerage firms, banks, dealers and similar organizations listed therein that a dividend confirmation had previously been distributed to such firms by Scilex\u2019s transfer agent and requests that such firms contact Scilex\u2019s transfer agent if they have not received such confirmation. The supplement also reiterates a question related to issues that may arise with respect to the dividend in connection with short positions in Sorrento common stock.<\/p>\n

The supplement to the FAQs and related annex are included in this press release and can also be found Scilex\u2019s website https:\/\/www.scilexholding.com\/investors\/faqs\/<\/a><\/p>\n

\n SUPPLEMENT TO <\/strong>
\n
\n FREQUENTLY ASKED QUESTIONS <\/strong>
\n
\n REGARDING THE DIVIDEND OF SCILEX HOLDING COMPANY COMMON STOCK BY SORRENTO THERAPEUTICS, INC.<\/strong>\n <\/p>\n

This supplement is a supplement to the Frequently Asked Questions Regarding the Dividend of Scilex Holding Company Common Stock by Sorrento Therapeutics, Inc. (Sorrento<\/u>) that was issued by Sorrento on January 29, 2023 (the FAQ<\/u>), a copy of which can be found under the \u201cInvestors\u201d section of its website at\u00a0www.sorrentotherapeutics.com<\/a>. <\/u><\/p>\n

This supplement is being issued to update and supplement the information in the FAQ to notify investors regarding certain matters relating to the dividend and reiterate certain questions and answers from the FAQ. Capitalized terms used in this supplement shall have their respective meetings set forth in the FAQ.<\/p>\n

\n NOTICE OF REMOVAL OF CONTRA-CUSIP BY DTCC<\/strong>\n <\/p>\n

\n Effective as of February 2, 2023, the Depository Trust and Clearing Corporation has removed the \u201ccontra-CUSIP\u201d that it had previously imposed on the Dividend Stock. Any shares of Dividend Stock held by your brokerage firm, bank, dealer or other similar organization for your benefit now bear only Scilex\u2019s CUSIP number, which is 80880W106. If you are entitled to receive Dividend Stock, please contact your brokerage firm, bank, or other similar organization immediately to confirm that the CUSIP number appears on your brokerage statement with respect to your Dividend Stock.<\/strong>\n <\/p>\n

\n NOTICE TO BROKERAGE FIRMS, BANKS, DEALERS AND OTHER SIMILAR ORGANIZATIONS<\/strong>\n <\/p>\n

\n If the name of your firm, bank or other similar organization is set forth on Annex B of the FAQ, which Annex B is repeated below for convenience, and your firm, bank or similar organization has not received the Dividend Confirmation that was mailed to your firm, bank or similar organization, please contact Scilex\u2019s transfer agent immediately to obtain a copy of the Dividend Confirmation. Scilex\u2019s transfer agent\u2019s contact information is as follows:<\/strong>\n <\/p>\n

\n Continental Stock Transfer & Trust Company<\/strong>\n <\/p>\n

\n Telephone Number<\/strong>: 800-509-5586<\/p>\n

\n Email Address<\/strong>: cstmail@continentalstock.com<\/p>\n

\n Several major brokers have confirmed to Sorrento and Scilex that they are adding the Scilex share positions to the individual brokerage accounts of Sorrento shareholders receiving the Dividend Stock<\/strong>\n <\/p>\n

\n SUPPLEMENTAL QUESTION AND ANSWER<\/strong>\n <\/p>\n

\n Q:\u00a0If I loaned my shares of Sorrento common stock to short sellers or any other party as of the Record Date, am I still entitled to receive Dividend Stock as of the Payment Date?\u00a0<\/strong>\n <\/p>\n

A: Only Record Holders as of the Record Date are entitled to receive the Dividend Stock. If you were the Record Holder as of the Record Date and are entitled to receive the Dividend Stock, but have not received the Dividend Stock, you may be entitled to receive Dividend Stock from the short seller or other party who borrowed your shares of Sorrento common stock, whether through the lending programs implemented by your brokerage firm, bank, dealer and other similar organization or otherwise. If you were a Record Holder as of the Record Date and have not received your Dividend Stock, please consult with your financial advisor, broker or other agent immediately to determine how to receive your Dividend Stock.<\/strong><\/p>\n

\n Annex B<\/strong>\n <\/p>\n

\n Broker List<\/strong>\n <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n
\n Broker Name<\/u>
\n <\/strong>\n <\/td>\n		\n
\n Broker Address<\/u>
\n <\/strong>\n <\/td>\n		\u00a0<\/td>\n\n
\n Broker Name<\/u>
\n <\/strong>\n <\/td>\n		\n
\n Broker Address<\/u>
\n <\/strong>\n <\/td>\n<\/tr>\n
ABN AMRO CLEARING CHICAGO LLC<\/td>\n175 WEST JACKSON BLVD.
CHICAGO
IL ILLINOIS
60604 US<\/td>\n		\u00a0<\/td>\nAlbert Fried & Company LLC<\/td>\n45 BROADWAY, 24TH FLOOR
24TH FLOOR
NEW YORK
NY NEW YORK
10006 US<\/td>\n<\/tr>\n
AMALGAMATED BANK<\/td>\n275 7TH AVENUE
NEW YORK
NY NEW YORK
10003 US<\/td>\n		\u00a0<\/td>\nAMERICAN ENTERPRISE INVESTMENT SERVICES INC.<\/td>\n682 AMERIPRISE FINANCIAL CENTER
MINNEAPOLIS
MN MINNESOTA
55474 US<\/td>\n<\/tr>\n
APEX CLEARING CORPORATION<\/td>\n2 GATEWAY CENTER 283-299 MARKET ST
16TH FLOOR
NEWARK
NJ NEW JERSEY
07102-5005 US<\/td>\n		\u00a0<\/td>\nBANK OF AMERICA, NA\/GWIM TRUST OPERATIONS<\/td>\n901 MAIN STREET
12TH FLOOR
DALLAS
TX TEXAS
23113 US<\/td>\n<\/tr>\n
BANK OF NEW YORK MELLON<\/td>\n111 SANDERS CREEK PARKWAY 2ND FLOOR
2ND FLOOR
EAST SYRACUSE
NY NEW YORK
13057 US.<\/td>\n		\u00a0<\/td>\nBARCLAYS CAPITAL INC.<\/td>\nDTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZ
JERSEY CITY
NJ NEW JERSEY
07310 US<\/td>\n<\/tr>\n
BARCLAYS CAPITAL INC.<\/td>\nDTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZ
JERSEY CITY
NJ NEW JERSEY
07310 US<\/td>\n		\u00a0<\/td>\nBMO CAPITAL MARKETS CORP.<\/td>\n3 2ND STREET
12TH FLOOR
JERSEY CITY
NJ NEW JERSEY
07302 US<\/td>\n<\/tr>\n
BMO HARRIS BANK NA\/TRUST<\/td>\n11270 W PARK PL
MILWAUKEE
WI WISCONSIN
53224 US<\/td>\n		\u00a0<\/td>\nBMO Nesbitt Burns Inc., Toronto<\/td>\n250 YONGE STREET, 7TH FLOOR
7TH FLOOR
TORONTO
ON ONTARIO
M5B 2M8 CA CANADA<\/td>\n<\/tr>\n
BNP PARIBAS, NEW YORK BRANCH\/BNP PARIBAS PRIME BROKERAGE CUSTODIAN<\/td>\n100 WEST 33RD STREET
3RD FLOOR
NEW YORK
NY NEW YORK
10001<\/td>\n		\u00a0<\/td>\nBNP PARIBAS, NEW YORK BRANCH\/BNP PARIBAS PRIME BROKERAGE CUSTODIAN<\/td>\n100 WEST 33RD STREET
3RD FLOOR
NEW YORK
NY NEW YORK
10001<\/td>\n<\/tr>\n
BNY MELLON<\/td>\nPO BOX 392002
500 ROSS STREET
PITTSBURGH
PA PENNSYLVANIA
15262 US<\/td>\n		\u00a0<\/td>\nBNY MELLON\/WEALTH MANAGEMENT<\/td>\n1 FREEDOM VALLEY DRIVE
OAKS
PA PENNSYLVANIA
19456 US<\/td>\n<\/tr>\n
BNYMELLON<\/td>\n111 SANDERS CREEK PARKWAY 2ND FLOOR
2ND FLOOR
EAST SYRACUSE
NY NEW YORK
13057 US<\/td>\n		\u00a0<\/td>\nBNYMELLON\/RE BARCLAYS CAPITAL SECURITIES LTD.<\/td>\nONE WALL STREET
NEW YORK
NY NEW YORK
10286<\/td>\n<\/tr>\n
BNYMELLON\/RE CACEIS BANK LUXEMBOURG<\/td>\n500 Grant St.
BNY Mellon Center
PITTSBURGH
PA PENNSYLVANIA
15258<\/td>\n		\u00a0<\/td>\nBNYMELLON\/RE CACEIS BANK, NETHERLANDS<\/td>\n111 SANDERS CREEK PARKWAY
EAST SYRACUSE
NY NEW YORK
13057<\/td>\n<\/tr>\n
BNYMELLON\/RE CHARLES STANLEY AND COMPANY, LIMITED<\/td>\n111 SANDERS CREEK PARKWAY 2ND FLOOR
2ND FLOOR
EAST SYRACUSE
NY NEW YORK
13057 US<\/td>\n		\u00a0<\/td>\nBNYMELLON\/RE ETF – ISHARES DTC\/NSCC<\/td>\n111 SANDERS CREEK PARKWAY
EAST SYRACUSE
NY NEW YORK
13057<\/td>\n<\/tr>\n
BNYMELLON\/RE WINTERFLOOD SECURITIES LTD<\/td>\n500 Grant St.
BNY Mellon Center
PITTSBURGH
PA PENNSYLVANIA
15258<\/td>\n		\u00a0<\/td>\nBOFA<\/td>\n4804 Deer Lake Drive East
FL9-803-04-04- 4th floor
JACKSONVILLE
FL FLORIDA
32246 US<\/td>\n<\/tr>\n
BOFA<\/td>\n4804 Deer Lake Drive East
FL9-803-04-04- 4th floor
JACKSONVILLE
FL FLORIDA
32246 US<\/td>\n		\u00a0<\/td>\nBOFA SECURITIES INC<\/td>\n4804 Deer Lake Drive East
FL9-803-04-04- 4th floor
JACKSONVILLE
FL FLORIDA
32246 US<\/td>\n<\/tr>\n
BROWN BROTHERS HARRIMAN & CO.<\/td>\n140 BROADWAY
ATTN: CORPORATE ACTIONS VAULT
NEW YORK
NY NEW YORK
10005 US<\/td>\n		\u00a0<\/td>\nBROWN BROTHERS HARRIMAN & CO.\/ETF<\/td>\n140 BROADWAY
NEW YORK
NY NEW YORK
10005<\/td>\n<\/tr>\n
CALDWELL SECURITIES LTD.\/CDS**<\/td>\n55 UNIVERSITY AVENUE
SUITE 340
TORONTO
ON ONTARIO
M5J 2H7 CANADA<\/td>\n		\u00a0<\/td>\nCANACCORD GENUITY CORP.<\/td>\n609 GRANVILLE ST
VANCOUVER
BC BRITISH COLUMBIA
V7Y 1H2 CA CANADA<\/td>\n<\/tr>\n
CANTOR, FITZGERALD & CO.<\/td>\n135 E 57TH ST 5TH FL
NEW YORK
NY NEW YORK
10041 US<\/td>\n		\u00a0<\/td>\nCDS CLEARING AND DEPOSITORY SERVICES INC.<\/td>\n100 ADELAIDE STREET WEST
TORONTO
ON ONTARIO
M5H 1S3 CA CANADA<\/td>\n<\/tr>\n
CETERA INVESTMENT SERVICES LLC<\/td>\n400 FIRST STREET SOUTH, SUITE 300
SUITE 300
ST. CLOUD
MN MINNESOTA
56302-0283 US<\/td>\n		\u00a0<\/td>\nCHARLES SCHWAB & CO., INC.<\/td>\n211 MAIN STREET
SAN FRANCISCO
CA CALIFORNIA
94105 US<\/td>\n<\/tr>\n
CI INVESTMENT SERVICES INC.<\/td>\n199 BAY STREET
SUITE 2600
TORONTO
ON ONTARIO
M5L 1E2 CA CANADA<\/td>\n		\u00a0<\/td>\nCIBC WORLD MARKETS INC.\/CDS**<\/td>\n161 BAY STREET 10 FL
TORONTO
ON ONTARIO
M5J 2S8 CA CANADA<\/td>\n<\/tr>\n
CITIBANK, N.A.\/ETF<\/td>\n3800 CITIGROUP CENTER
B2\/2
TAMPA
FL FLORIDA
33610<\/td>\n		\u00a0<\/td>\nCITIBANK, NATIONAL ASSOCIATION<\/td>\n3800 CITIBANK CENTER TAMPA
BLDG.B FIRST FLOOR ZONE 8
TAMPA
FL FLORIDA
33610-9122 US<\/td>\n<\/tr>\n
CITIGROUP GLOBAL MARKETS, INC.<\/td>\n580 CROSSPOINT PARKWAY
GETZVILLE
NY NEW YORK
14068 US<\/td>\n		\u00a0<\/td>\nCLEAR STREET LLC<\/td>\n4 World Trade Center, 45th Floor
150 Greenwich Street
NEW YORK
NY NEW YORK
10007<\/td>\n<\/tr>\n
CLEARSTREET IO<\/td>\n55 BROADWAY (SUITE 2102)
CORPORATE ACTIONS
NEW YORK
NEW YORK
10006 US<\/td>\n		\u00a0<\/td>\nCOMMERCE BANK<\/td>\n922 WALNUT STREET
MAIL STOP TBTS-2
KANSAS CITY
MO MISSOURI
64106 US<\/td>\n<\/tr>\n
COR CLEARING LLC<\/td>\n9300 UNDERWOOD AVE
SUITE 400
OMAHA
NE NEBRASKA
68114 US<\/td>\n		\u00a0<\/td>\nCredential Securities Inc.<\/td>\n800-1111 WEST GEORGIA STREET
VANCOUVER
BC BRITISH COLUMBIA
V6E 4T6 CA CANADA<\/td>\n<\/tr>\n
CREST INTERNATIONAL NOMINEES LIMITED<\/td>\n33 CANNON STREET
LONDON
EC4M 5SB GB UNITED KINGDO<\/td>\n		\u00a0<\/td>\nCURVATURE SECURITIES, LLC<\/td>\n39 MAIN STREET
CHATHAM
NJ NEW JERSEY
07928 US<\/td>\n<\/tr>\n
D.A. DAVIDSON & CO.<\/td>\n8 3RD STREET NORTH
GREAT FALLS
MT MONTANA
59401 US<\/td>\n		\u00a0<\/td>\nDEPOSITO CENTRAL DE VALORES S.A., DEPOSITO DE VALORES<\/td>\nAVENIDA APOQUINDO # 4001
FLOOR 12, C.P.
7550162, SANTIAGO
CL CHILE<\/td>\n<\/tr>\n
DESJARDINS SECURITIES INC.<\/td>\n1253 McGill College
10TH FLOOR
MONTREAL
QUEBEC
H3B 2Y5 CA CANADA<\/td>\n		\u00a0<\/td>\nDEUTSCHE BANK AG NY\/US CUSTODY<\/td>\n1251 Avenue Of The Americas
NEW YORK
NY NEW YORK
10020<\/td>\n<\/tr>\n
DEUTSCHE BANK SECURITIES INC.<\/td>\n60 WALL STREET
9TH FLOOR
NEW YORK
NY NEW YORK
10005 US<\/td>\n		\u00a0<\/td>\nDRIVEWEALTH, LLC<\/td>\n15 EXCHANGE PLACE
10TH FLOOR
JERSEY CITY
NEW JERSEY
07302<\/td>\n<\/tr>\n
E*TRADE CLEARING LLC<\/td>\nHARBORSIDE FINANCIAL CENTER
501 PLAZA 11
JERSEY CITY
NJ NEW JERSEY
07311 US<\/td>\n		\u00a0<\/td>\nEDWARD D. JONES & CO., L.P.<\/td>\n12555 MANCHESTER ROAD
ST. LOUIS
MO MISSOURI
63131-3729 US<\/td>\n<\/tr>\n
EDWARD D. JONES & CO., L.P.<\/td>\n201 PROGRESS PARKWAY
MARYLAND HEIGHTS
MO MISSOURI
63043 US<\/td>\n		\u00a0<\/td>\nFIDELITY CLEARING CANADA ULC\/CDS**<\/td>\n483 BAY ST.
SOUTH TOWER
TORONTO
ON ONTARIO
M5G2N7 CA CANADA<\/td>\n<\/tr>\n
FIFTH THIRD BANK<\/td>\n5001 KINGSLEY DRIVE
MAIL DROP 1MOB28
CINCINNATI
OH OHIO
45227 US<\/td>\n		\u00a0<\/td>\nFOLIO INVESTMENTS, INC.<\/td>\n8180 GREENSBORO DRIVE
8TH FLOOR
MCLEAN
VA VIRGINIA
22102 US<\/td>\n<\/tr>\n
FUTU CLEARING INC.<\/td>\n12750 Merit Drive
SUITE 475
DALLAS
TX TEXAS
75251<\/td>\n		\u00a0<\/td>\nGMP SECURITIES L.P.<\/td>\n145 KING STREET WEST, SUITE 300
11TH FLOOR
TORONTO
ON ONTARIO
MJ5 1J8 CA CANADA<\/td>\n<\/tr>\n
GOLDMAN, SACHS & CO. LLC<\/td>\n222 SOUTH MAIN STREET
Attn: Mandatory Corporate Actions
SALT LAKE CITY
UT UTAH
84101 US<\/td>\n		\u00a0<\/td>\nHAYWOOD SECURITIES INC.\/CDS**<\/td>\n200 BURRARD ST
WATERFRONT CENTRE SUITE 700
VANCOUVER
BC BRITISH COLUMBIA
V6C 3L6 CANADA<\/td>\n<\/tr>\n
HILLTOP SECURITIES INC.<\/td>\n1201 ELM ST.
35TH FLOOR
DALLAS
TX TEXAS
75270 US<\/td>\n		\u00a0<\/td>\nHRT FINANCIAL LLC<\/td>\n150 GREENWICH STREET (ATTN: SETTLEMENT) FOUR WORLD TRADE CENTER
57TH FLOOR
NEW YORK
NY NEW YORK
10007 US<\/td>\n<\/tr>\n
HSBC BANK USA, NA\/HSBC CUSTODY & CLEARING SERVICES FOR STOCK LOAN<\/td>\n452 FIFTH AVENUE
ATTN: HBUS CCS SETTS
NEW YORK
NY NEW YORK
10018 US<\/td>\n		\u00a0<\/td>\nHSBC BANK USA, NATIONAL ASSOCIATION<\/td>\n452 FIFTH AVENUE
ATTN: HBUS CCS SETTS
NEW YORK
NEW YORK
10018 US<\/td>\n<\/tr>\n
INTERACTIVE BROKERS LLC<\/td>\n2 PICKWICK PLAZA
2ND FLOOR
GREENWICH
CT CONNECTICUT
06830 US<\/td>\n		\u00a0<\/td>\nJ.P. MORGAN CHASE BANK NA\/FBO BLACKROCK CTF<\/td>\n1111 POLARIS PARKWAY
COLUMBUS
OH OHIO
43240<\/td>\n<\/tr>\n
J.P. MORGAN CLEARING CORP.<\/td>\nFOUR CHASE METROTECH CENTER
3RD FLOOR
BROOKLYN
NY NEW YORK
11201 US<\/td>\n		\u00a0<\/td>\nJANNEY MONTGOMERY SCOTT LLC<\/td>\n1717 ARCH STREET
17TH FLOOR
PHILADELPHIA
PA PENNSYLVANIA
19103 US<\/td>\n<\/tr>\n
JEFFERIES LLC<\/td>\n101 HUDSON STREET, 11th Floor
NEW JERSEY
NJ NEW JERSEY
07302 US<\/td>\n		\u00a0<\/td>\nJPMORGAN CHASE BANK, NATIONAL ASSOCIATION<\/td>\nFOUR CHASE METROTECH CENTER
3RD FLOOR
BROOKLYN
NY NEW YORK
11201 US<\/td>\n<\/tr>\n
JPMORGAN CHASE BANK\/EUROCLEAR BANK<\/td>\nFOUR CHASE METROTECH CENTER
3RD FLOOR
BROOKLYN
NY NEW YORK
11245 US<\/td>\n		\u00a0<\/td>\nJPMORGAN CHASE BANK\/IA<\/td>\nFOUR CHASE METROTECH CENTER
3RD FLOOR
BROOKLYN
NY NEW YORK
11201 US<\/td>\n<\/tr>\n
KEYBANK NATIONAL ASSOCIATION<\/td>\n4900 TIEDEMAN RD
BROOKLYN
OH OHIO
44144 US<\/td>\n		\u00a0<\/td>\nLAURENTIAN BANK SECURITIES INC.<\/td>\n1981 MCGILL COLLEGE AVE.
SUITE 100
MONTREAL
QUEBEC
H3A 3K3 CA CANADA<\/td>\n<\/tr>\n
LPL FINANCIAL LLC<\/td>\n4707 EXECUTIVE DRIVE
SAN DIEGO
CA CALIFORNIA
92121 US<\/td>\n		\u00a0<\/td>\nMANUFACTURERS AND TRADERS TRUST COMPANY<\/td>\nONE M&T PLAZA
TRUST OPS 8TH FLOOR
BUFFALO
NY NEW YORK
14203 US<\/td>\n<\/tr>\n
MANULIFE SECURITIES INCORPORATED<\/td>\n1235 NORTH SERVICE ROAD WEST
OAKVILLE
ON ONTARIO
L6M 2W2 CA CANADA<\/td>\n		\u00a0<\/td>\nMARSCO INVESTMENT CORPORATION<\/td>\n101 EISENHOWER PARKWAY
ROSELAND
NJ NEW JERSEY
07068 US<\/td>\n<\/tr>\n
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED<\/td>\n4804 Deer Lake Drive East
FL9-803-04-04- 4th floor
JACKSONVILLE
FL FLORIDA
32246 US<\/td>\n		\u00a0<\/td>\nMIRAE ASSET SECURITIES (USA) INC.\/STOCK LOAN CONDUIT ACCOUNT<\/td>\n810 SEVENTH AVE
37TH FLOOR
NEW YORK
NY NEW YORK
10019<\/td>\n<\/tr>\n
MIRAE ASSET SECURITIES (USA), INC.<\/td>\n810 SEVENTH AVE
37TH FLOOR
NEW YORK
NY NEW YORK
10019<\/td>\n		\u00a0<\/td>\nMITSUBISHI UFJ TRUST & BANKING CORPORATION, NEW YORK BRANCH<\/td>\n280 PARK AVE
39TH FL-WEST BLDG
NEW YORK
NY NEW YORK
10017<\/td>\n<\/tr>\n
Morgan Stanley<\/td>\n1300 THAMES STREET
THAMES STREET WHARF
BALTIMORE
MD MARYLAND
21231 US<\/td>\n		\u00a0<\/td>\nMORGAN STANLEY & CO. LLC<\/td>\n1300 THAMES ST.
BALTIMORE
MD MARYLAND<\/td>\n<\/tr>\n
MORGAN STANLEY SMITH BARNEY LLC<\/td>\n1 NEW YORK PLAZA
39TH FLOOR
NEW YORK
NY NEW YORK
10004 US<\/td>\n		\u00a0<\/td>\nMURIEL SIEBERT & CO., INC.<\/td>\n77 SUMMER STREET
3RD FLOOR
BOSTON
MA MASSACHUSETTS
02210 US<\/td>\n<\/tr>\n
NATIONAL FINANCIAL SERVICES LLC<\/td>\n499 WASHINGTON BOULEVARD
5TH FLOOR
JERSEY CITY
NJ NEW JERSEY
07310 US<\/td>\n		\u00a0<\/td>\nNBCN INC.<\/td>\n1010 rue De La Gaucheti\u00e8re
Mezzanine 100
MONTREAL
QUEBEC
H3B 5J2 CA CANADA<\/td>\n<\/tr>\n
NOMURA INTERNATIONAL TRUST COMPANY<\/td>\n309 WEST 49TH STREET
10TH FLOOR
NEW YORK
NY NEW YORK
10019 US<\/td>\n		\u00a0<\/td>\nODLUM BROWN LIMITED<\/td>\n250 HOWE STREET
SUITE 1100
VANCOUVER
BC BRITISH COLUMBIA
V6C 3R8 CA CANADA<\/td>\n<\/tr>\n
OPPENHEIMER & CO. INC.<\/td>\n85 BROAD STREET
NEW YORK
NY NEW YORK
10004 US<\/td>\n		\u00a0<\/td>\nPERSHING LLC<\/td>\n1 PERSHING PLAZA
JERSEY CITY
NJ NEW JERSEY
07399 US<\/td>\n<\/tr>\n
PHILLIP CAPITAL INC.<\/td>\n141 W. JACKSON BLVD. SUITE 3050
CHICAGO
IL ILLINOIS
60604 US<\/td>\n		\u00a0<\/td>\nPI FINANCIAL CORP.<\/td>\n666 BURRARD ST
SUITE 1900
VANCOUVER
BC BRITISH COLUMBIA
V6C 3N1 CA CANADA<\/td>\n<\/tr>\n
PNC BANK, NATIONAL ASSOCIATION<\/td>\n4100 W 150TH STREET
ASSET MOVEMENT TEAM 3RD FL, LOCATOR B7-YB17-03-03
CLEVELAND
OH OHIO
44135 US<\/td>\n		\u00a0<\/td>\nPRINCIPAL BANK<\/td>\n711 HIGH STREET
DES MOINES
IA IOWA
50392<\/td>\n<\/tr>\n
QUESTRADE INC.\/CDS**<\/td>\n5650 YONGE ST.,
Suite 1700
TORONTO
ON ONTARIO
M2M 4G3 CA CANADA<\/td>\n		\u00a0<\/td>\nRaymond James & Associates, Inc.<\/td>\n880 CARILLON PKWY
ST. PETERSBURG
FL FLORIDA
33733-2749 US<\/td>\n<\/tr>\n
RAYMOND JAMES LTD.<\/td>\n925 WEST GEORGIA STREET
SUITE 2200
VANCOUVER
BC BRITISH COLUMBIA
V6C 3L2 CA CANADA<\/td>\n		\u00a0<\/td>\nRBC CAPITAL MARKETS, LLC<\/td>\n60 SOUTH 6TH ST.
MINNEAPOLIS
MN MINNESOTA
55402 US<\/td>\n<\/tr>\n
RBC DOMINION SECURITIES INC<\/td>\n21 COMMERCE COURT SOUTH
2ND FLOOR
TORONTO
ON ONTARIO
M5L 1A7 CANADA<\/td>\n		\u00a0<\/td>\nRELIANCE TRUST COMPANY<\/td>\n1100 ABERNATHY RD.
500 NORTHPARK SUITE 400
ATLANTA
GA GEORGIA
30113 US<\/td>\n<\/tr>\n
RELIANCE TRUST COMPANY<\/td>\n4900 W. BROWN DEER RD
MILWAUKEE
WI WISCONSIN
53223 US<\/td>\n		\u00a0<\/td>\nROBERT W. BAIRD & CO. INCORPORATED<\/td>\n777 E WISCONSIN AVE
9TH FLOOR
MILWAUKEE
WI WISCONSIN
53202 US<\/td>\n<\/tr>\n
ROBINHOOD SECURITIES, LLC<\/td>\n500 COLONIAL CENTER PARKWAY
SUITE 100
LAKE MARY
FL FLORIDA
32746 US<\/td>\n		\u00a0<\/td>\nSAFRA SECURITIES LLC<\/td>\n546 5TH AVENUE
NEW YORK
NY NEW YORK
10036 US<\/td>\n<\/tr>\n
SCOTIA CAPITAL (USA) INC.<\/td>\n150 KING STREET W
5TH FLOOR
TORONTO
ON ONTARIO
M5H 1J9 CA CANADA<\/td>\n		\u00a0<\/td>\nSEI PRIVATE TRUST COMPANY<\/td>\n1 FREEDOM VALLEY DRIVE
OAKS
PA PENNSYLVANIA
19456 US<\/td>\n<\/tr>\n
SEI PRIVATE TRUST COMPANY<\/td>\n1 FREEDOM VALLEY DRIVE
OAKS
PA PENNSYLVANIA
19456 US<\/td>\n		\u00a0<\/td>\nSG AMERICAS SECURITIES, LLC<\/td>\n480 WASHINGTON BLVD.
20TH FLOOR
JERSEY CITY
NJ NEW JERSEY
07310 US<\/td>\n<\/tr>\n
SSB – BLACKROCK INSTITUTIONAL TRUST<\/td>\n50 California Street
San Francisco
CA CALIFORNIA
94163<\/td>\n		\u00a0<\/td>\nSSB – TRUST CUSTODY<\/td>\n30 ADELAIDE ST EAST
SUITE 800
TORONTO
ON ONTARIO
M5C 3G6 CA CANADA<\/td>\n<\/tr>\n
SSB&T CO\/CLIENT CUSTODY SERVICES<\/td>\n1776 HERITAGE DRIVE
NORTH QUINCY
MA MASSACHUSETTS
02171<\/td>\n		\u00a0<\/td>\nSTATE STREET BANK & TRUST CO<\/td>\n16 WALL STREET
5TH FLOOR
NEW YORK
NY NEW YORK
10005 US<\/td>\n<\/tr>\n
STATE STREET BANK & TRUST COMPANY \/ ISHARES EUROPE<\/td>\n1776 HERITAGE DRIVE
NORTH QUINCY
MA MASSACHUSETTS
02171<\/td>\n		\u00a0<\/td>\nSTATE STREET BANK & TRUST\/STATE STREET TOTALETF<\/td>\n1776 Heritage Drive
NORTH QUINCY
MA MASSACHUSETTS
02717<\/td>\n<\/tr>\n
STATE STREET BANK AND TRUST COMPANY<\/td>\n30 ADELAIDE ST EAST
SUITE 800
TORONTO
ON ONTARIO
M5C 3G6 CA CANADA<\/td>\n		\u00a0<\/td>\nSTIFEL, NICOLAUS & COMPANY, INCORPORATED<\/td>\n501 N BROADWAY
ST. LOUIS
MO MISSOURI
63102 US<\/td>\n<\/tr>\n
STONEX FINANCIAL INC.<\/td>\n2 PERIMETER PARK SOUTH
SUITE 100 W
BIRMINGHAM
AL ALABAMA
35243 US<\/td>\n		\u00a0<\/td>\nTD AMERITRADE CLEARING, INC.<\/td>\n200 S 108TH AVE
OMAHA
NE NEBRASKA
68154 US<\/td>\n<\/tr>\n
TD WATERHOUSE CANADA INC
ATTN: MANDATORY CORPORATE ACTIONS<\/td>\n		77 BLOOR STREET WEST
3RD FLOOR
TORONTO
ON ONTARIO
M5S 1M2 CA CANADA<\/td>\n		\u00a0<\/td>\nTEXAS TREASURY SAFEKEEPING TRUST COMPANY<\/td>\n208 E 10TH ST
AUSTIN
TX TEXAS
78701 US<\/td>\n<\/tr>\n
THE BANK OF NEW YORK MELLON<\/td>\n500 GRANT STREET
27TH FLOOR
PITTSBURGH
PA PENNSYLVANIA
15258 US<\/td>\n		\u00a0<\/td>\nTHE HUNTINGTON NATIONAL BANK<\/td>\n7 EASTON OVAL EA4E62
COLUMBUS
OH OHIO
43209 US<\/td>\n<\/tr>\n
THE NORTHERN TRUST COMPANY<\/td>\n333 South Wabash Ave, 32nd Floor
Attn: Trade Securities Processing
CHICAGO
IL ILLINOIS
60603 US<\/td>\n		\u00a0<\/td>\nTRADESTATION SECURITIES, INC.<\/td>\n120 RIVERSIDE PLAZA
SUITE 1650
CHICAGO
IL ILLINOIS
60606 US<\/td>\n<\/tr>\n
U.S. BANCORP INVESTMENTS, INC.<\/td>\n60 LIVINGSTON AVE
EP-MN-WN1B
ST. PAUL
MN MINNESOTA
55107-1419 US<\/td>\n		\u00a0<\/td>\nU.S. BANK N.A.\/ETF<\/td>\n1555 N RIVER CENTER DRIVE
MILWAUKEE
WI WISCONSIN
53212<\/td>\n<\/tr>\n
U.S. BANK NATIONAL ASSOCIATION<\/td>\n1555 NORTH RIVERCENTER DRIVE, SUITE 302
SUITE 302
MILWAUKEE
WI WISCONSIN
53212 US<\/td>\n		\u00a0<\/td>\nUBS AG<\/td>\n480 WASHINGTON BLVD.
12TH FLOOR
JERSEY CITY
NJ NEW JERSEY
07310 US<\/td>\n<\/tr>\n
UBS FINANCIAL SERVICES INC.<\/td>\n1000 HARBOR BOULEVARD
WEEHAWKEN
NJ NEW JERSEY
07086 US<\/td>\n		\u00a0<\/td>\nUBS SECURITIES LLC<\/td>\n677 WASHINGTON BLVD
STAMFORD
CT CONNECTICUT
06901 US<\/td>\n<\/tr>\n
UMB BANK, NATIONAL ASSOCIATION<\/td>\n928 GRAND BLVD
KANSAS CITY
MO MISSOURI
64106 US<\/td>\n		\u00a0<\/td>\nVANGUARD MARKETING CORPORATION<\/td>\n100 VANGUARD BLVD
MALVERN
PA PENNSYLVANIA
19355 US<\/td>\n<\/tr>\n
VELOCITY CLEARING, LLC<\/td>\n1301 Route 36
Suite 109 (Attn: Chris Felicetti)
HAZLET
NEW JERSEY
7730 US<\/td>\n		\u00a0<\/td>\nVELOX CLEARING LLC<\/td>\n2400 E. KATELLA AVENUE
SUITE 725A
ANAHEIM
CA CALIFORNIA
92806 US<\/td>\n<\/tr>\n
VIRTU AMERICAS LLC<\/td>\nONE LIBERTY PLAZA, 165 BROADWAY
5TH FLOOR
NEW YORK
NY NEW YORK
10006 US<\/td>\n		\u00a0<\/td>\nVISION FINANCIAL MARKETS LLC<\/td>\n4 HIGH RIDGE PARK
SUITE 100
STAMFORD
CT CONNECTICUT
06905 US<\/td>\n<\/tr>\n
WEDBUSH SECURITIES INC<\/td>\n1000 WILSHIRE BLVD
8TH FLOOR
LOS ANGELES
CA CALIFORNIA
90017 US<\/td>\n		\u00a0<\/td>\nWEDBUSH SECURITIES INC.<\/td>\n1000 WILSHIRE BLVD.
LOS ANGELES
CA CALIFORNIA
90017 US<\/td>\n<\/tr>\n
WELLS FARGO BANK, N.A.\/SIG<\/td>\n733 MARQUETTE AVE 4TH FLOOR
MAC N9306-04D
MINNEAPOLIS
MN MINNESOTA
55402 US<\/td>\n		\u00a0<\/td>\nWELLS FARGO CLEARING SERVICES LLC<\/td>\n1 NORTH JEFFERSON
MAIL CODE: H0006-094
ST. LOUIS
MO MISSOURI
63103 US<\/td>\n<\/tr>\n
WELLS FARGO SECURITIES, LLC<\/td>\n1525 WEST W T HARRIS BLVD
CHARLOTTE
NC NORTH CAROLINA
28262 US<\/td>\n		\u00a0<\/td>\nWILSON-DAVIS & CO., INC.<\/td>\n236 SOUTH MAIN STREET
SALT LAKE CITY
UT UTAH
84101 US<\/td>\n<\/tr>\n<\/table>\n

\n About Scilex Holding Company\u00a0<\/strong>\n <\/p>\n

Scilex Holding Company, a majority-owned by Sorrento Therapeutics, Inc., is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Scilex is uncompromising in its focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life. Results from the Phase III Pivotal Trial C.L.E.A.R Program for SEMDEXA\u2122, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022.\u00a0 Scilex has applied for breakthrough therapy designation and expects to seek priority review for SEMDEXA\u2122\u00a0for the treatment of sciatica.\u00a0 Scilex targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with moderate to severe pain.\u00a0 Scilex launched its first commercial product in October 2018, in-licensed a commercial product in June 2022, and is developing its late-stage pipeline, which includes a pivotal Phase 3 candidate and one Phase 2 and one Phase 1 candidate.\u00a0 Its commercial product, ZTlido\u00ae (lidocaine topical system) 1.8%, or ZTlido\u00ae, is a prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain.\u00a0 Scilex in-licensed the exclusive right to commercialize Gloperba\u00ae (colchicine USP) oral solution, an FDA-approved prophylactic treatment for painful gout flares in adults, in the U.S. Scilex is planning to commercialize Gloperba\u00ae in 2023 and is well-positioned to market and distribute the product. Scilex\u2019s three product candidates are SP-102 (injectable dexamethasone sodium phosphate viscous gel product containing 10 mg dexamethasone), or SEMDEXA\u2122, a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, with FDA Fast Track status; SP-103 (lidocaine topical system) 5.4%, a Phase 2, triple-strength formulation of ZTlido\u00ae, for the treatment of low back pain, with FDA Fast Track status; and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule, for the treatment of chronic pain, fibromyalgia that has completed multiple Phase 1 trial programs and expected to initiate Phase 2 trials this year. For further information regarding the SP-102 Phase 3 efficacy trial, see NCT identifier NCT03372161 \u2013\u00a0Corticosteroid Lumbar Epidural Analgesia for Radiculopathy \u2013 Full Text View \u2013 ClinicalTrials.gov<\/a>.<\/p>\n

Scilex Holding Company is headquartered in Palo Alto, California, with operations in both Palo Alto and San Diego, California. For further information please visit\u00a0www.scilexholding.com<\/a>.<\/p>\n

\n About Sorrento Therapeutics, Inc.<\/strong>\n <\/p>\n

Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento’s multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as Abivertinib, next-generation tyrosine kinase inhibitors (\u201cTKIs\u201d), fully human antibodies (\u201cG-MAB\u2122 library\u201d), immuno-cellular therapies (\u201cDAR-T\u2122\u201d), antibody-drug conjugates (\u201cADCs\u201d), and oncolytic virus (\u201cSeprehvec\u2122\u201d). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including STI-1558, COVI-MSC\u2122; and diagnostic test solutions, including COVIMARK\u2122.<\/p>\n

Sorrento’s commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a TRPV1 agonist, non-opioid pain management small molecule, resiniferatoxin (\u201cRTX\u201d), and SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA\u2122), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, and to commercialize ZTlido\u00ae (lidocaine topical system) 1.8% for the treatment of postherpetic neuralgia (PHN). RTX has been cleared for a Phase II trial for intractable pain associated with cancer and a Phase II trial in osteoarthritis patients. Positive final results from the Phase III Pivotal Trial C.L.E.A.R. Program for SEMDEXA\u2122, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in\u00a0March 2022. ZTlido\u00ae was approved by the FDA on\u00a0February 28, 2018.<\/p>\n

For more information visit\u00a0www.sorrentotherapeutics.com<\/a>.<\/p>\n

\n Contacts:<\/strong>\n <\/p>\n

For Scilex Holding Company<\/p>\n

Jaisim Shah
Chief Executive Officer
Scilex Holding Company
960 San Antonio Road
Palo Alto, CA 94303
Office: (650) 516-4310<\/p>\n

Email:\u00a0jshah@scilexpharma.com<\/a><\/p>\n

Website:\u00a0\u00a0www.sorrentotherapeutics.com<\/a>\u00a0and\u00a0www.scilexholding.com<\/a><\/p>\n

\n Investors and Media Contact:<\/strong>
\n
Elizabeth Czerepak
Email:\u00a0mediarelations@sorrentotherapeutics.com<\/a>
Website: www.sorrentotherapeutics.com<\/p>\n

Sorrento\u00ae and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.<\/p>\n

G-MAB\u2122, DAR-T\u2122, Seprehvec\u2122, SOFUSA\u2122, COVI-MSC\u2122, COVIMARK\u2122, Ovydso\u2122 and Fujovee\u2122\u00a0are trademarks of Sorrento Therapeutics, Inc.<\/p>\n

SEMDEXA\u2122 (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company.\u00a0 A proprietary name review by the FDA is planned.<\/p>\n

ZTlido\u00ae is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company.<\/p>\n

Gloperba\u00ae is an exclusive, transferable license to use the trademark by Scilex Holding Company.<\/p>\n

All other trademarks are the property of their respective owners.\u00a0<\/p>\n

\u00a9 2023 Sorrento Therapeutics, Inc. All Rights Reserved.<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc.\u00a0(Nasdaq: SRNE, \u201cSorrento\u201d) today posted a supplement to its previously issued \u201cFrequently Asked Questions\u201d document under the \u201cInvestors\u201d section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company held by Sorrento. The supplement to the FAQs provides notice regarding the Depository Trust and Clearing Corporation\u2019s removal of the contra-CUSIP on Scilex common stock that was distributed as a dividend to Sorrento\u2019s stockholders and provides notice to brokerage firms, banks, dealers and similar organizations listed therein that a dividend confirmation had previously been distributed to such firms by … <\/p>\n

Continue reading “Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-728322","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nScilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc.\u00a0(Nasdaq: SRNE, \u201cSorrento\u201d) today posted a supplement to its previously issued \u201cFrequently Asked Questions\u201d document under the \u201cInvestors\u201d section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company held by Sorrento. The supplement to the FAQs provides notice regarding the Depository Trust and Clearing Corporation\u2019s removal of the contra-CUSIP on Scilex common stock that was distributed as a dividend to Sorrento\u2019s stockholders and provides notice to brokerage firms, banks, dealers and similar organizations listed therein that a dividend confirmation had previously been distributed to such firms by … Continue reading "Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-02T18:18:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTk3MSM1Mzg5NDY2IzIwNDk4NDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"16 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock\",\"datePublished\":\"2023-02-02T18:18:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/\"},\"wordCount\":3256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MTk3MSM1Mzg5NDY2IzIwNDk4NDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/\",\"name\":\"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MTk3MSM1Mzg5NDY2IzIwNDk4NDQ=\",\"datePublished\":\"2023-02-02T18:18:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MTk3MSM1Mzg5NDY2IzIwNDk4NDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MTk3MSM1Mzg5NDY2IzIwNDk4NDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/","og_locale":"en_US","og_type":"article","og_title":"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock - Market Newsdesk","og_description":"PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc.\u00a0(Nasdaq: SRNE, \u201cSorrento\u201d) today posted a supplement to its previously issued \u201cFrequently Asked Questions\u201d document under the \u201cInvestors\u201d section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company held by Sorrento. The supplement to the FAQs provides notice regarding the Depository Trust and Clearing Corporation\u2019s removal of the contra-CUSIP on Scilex common stock that was distributed as a dividend to Sorrento\u2019s stockholders and provides notice to brokerage firms, banks, dealers and similar organizations listed therein that a dividend confirmation had previously been distributed to such firms by … Continue reading \"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-02T18:18:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTk3MSM1Mzg5NDY2IzIwNDk4NDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"16 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock","datePublished":"2023-02-02T18:18:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/"},"wordCount":3256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTk3MSM1Mzg5NDY2IzIwNDk4NDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/","name":"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTk3MSM1Mzg5NDY2IzIwNDk4NDQ=","datePublished":"2023-02-02T18:18:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTk3MSM1Mzg5NDY2IzIwNDk4NDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTk3MSM1Mzg5NDY2IzIwNDk4NDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scilex-holding-company-announces-that-its-majority-stockholder-sorrento-therapeutics-inc-has-issued-a-supplement-to-its-previously-issued-faq-regarding-the-dividend-of-scilex-hol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued \u201cFAQ\u201d Regarding the Dividend of Scilex Holding Company Common Stock"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=728322"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728322\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=728322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=728322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=728322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}